News Releases
C4C conect4children Project
11/12/2018C4C conect4children project update.
PARTNER Project
07/12/2018The 2nd Consortium Meeting of the 'ERN-PAEDCAN PARTNER: Paediatric Rare Tumours Network – European Registry' took place on 15 September in Gdańsk, Poland.
EU Action Plan Paediatrics Medicines Development
07/12/20182 Oct 2018: The EMA and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) published a joint action plan to support the development of medicines for children in Europe.
Young SIOPE
06/12/2018A new group, Young SIOPE, has been formed within SIOP Europe. The Group aims to develop a programme for young oncologists.
The Survivorship Passport
06/12/2018Stakeholders met in Brussels on 24 September 2018 to discuss the current status and challenges of the Survivorship Passport. The differences in long-term follow-up in different countries was discussed
The QUARTET Project and the SIOP Europe Paediatric Radiotherapy Working Group
06/12/2018The 2018 QUARTET group meeting: 16 October. The group gathered to discuss the status of the trials included in the QUARTET project, particularly those that will open shortly.
News Release: SIOP Europe 20th Anniversary Events
09/10/2018SIOP Europe at 20 Years
Brexit: the European Parliament’s role in prioritising patients, public health and health security a
21/09/2018With the Brexit clock ticking and with only six months left until the United Kingdom leaves the European Union, both sides are now preparing for a possible ’no deal’ Brexit, which could impact on patient and public health across the EU27.
Improving the care of children in Europe with rare cancer
03/09/2018SIOP Europe together with Coordinators for the PARTNER Project and ERN PaedCan highlight the importance of collaboration in order to improve the care of children in Europe with rare cancer.
‘The ‘Survivorship Passport’ for childhood cancer survivors’ is published in the European Journal of
21/08/2018The Survivorship Passport (SurPass) is a tool aiming to provide all European childhood cancer survivors with optimal long-term care.